Skip to main content
. 2011 Aug;66(8):1407–1411. doi: 10.1590/S1807-59322011000800017

Figure 3.

Figure 3

Time course of the mean arterial pressure (Δ MAP) and heart rate (Δ HR) following the intrathecal administration of an adenylate cyclase agonist (forskolin), a cAMP analog (dibutyryl-cAMP) or the vehicle (DMSO). *p<0.05 compared to DMSO.